Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Should aPS/PT Be Incorporated into the Routine Serological Tests in the Diagnosis of Antiphospholipid Syndrome?

SHULAN ZHANG, FENGCHUN ZHANG and YONGZHE LI
The Journal of Rheumatology January 2019, 46 (1) 114-116; DOI: https://doi.org/10.3899/jrheum.171402
SHULAN ZHANG
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FENGCHUN ZHANG
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YONGZHE LI
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: LiYZ{at}pumch.cn yongzhelipumch{at}126.com
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Correlations between multiple aPL and thrombosis (A), venous thrombosis (B), arterial thrombosis (C), and obstetrical complications (D). aPL: antiphospholipid antibodies; aPT/PS: antiprothrombin/antiphosphatidylserine antibodies; aCL: anticardiolipin antibodies; aβ2GPI: anti-β2-glycoprotein I; LA: lupus anticoagulants.

Tables

  • Figures
    • View popup
    Table 1.

    The predictive power of combination of various aPL in the diagnosis of APS. Except for likelihood ratios (LR), data are percentages.

    SensitivitySpecificityPPVNPVLR+LR–
    aPT/PS IgG or IgM or LAC79.7079.5085.3072.303.890.26
    aPT/PS IgG or IgM or aCL IgG or IgM78.8077.0083.7070.903.430.27
    aPT/PS IgG or IgM or anti-β2-GPI IgG or IgM73.4079.5084.3066.703.580.33
    LAC or aCL IgG or IgM or anti-β2-GPI IgG or IgM84.2084.5089.0078.205.420.19
    LAC or aCL IgG or IgM or anti-β2-GPI IgG or IgM or aPT/PS IgG or IgM87.1071.4082.0078.803.050.18
    aPT/PS IgG or IgM and LAC52.7099.4099.2058.4084.840.48
    aPT/PS IgG or IgM and aCL IgG or IgM46.9098.1097.4055.2025.160.54
    aPT/PS IgG or IgM and anti-β2-GPI IgG or IgM29.9098.8097.3048.5024.050.71
    aCL IgG or IgM and LAC46.9099.4099.1055.6075.490.53
    anti-β2-GPI IgG or IgM and LAC30.7098.8097.4048.8024.720.70
    LAC and aCL IgG or IgM and aPT/PS IgG or IgM38.60100.00100.0052.10NA0.61
    LAC and aCL IgG or IgM and anti-β2-GPI IgG or IgM29.5099.4098.6048.5047.430.71
    LAC and aCL IgG or IgM and anti-β2-GPI IgG or IgM and aPT/PS IgG or IgM23.20100.00100.0046.50NA0.77
    • aPL: antiphospholipid antibodies; APS: antiphospholipid syndrome; PPV: positive predictive value; NPV: negative predictive value; NA: not applicable; aPT/PS: antiphosphatidylserine/prothrombin antibodies; aCL: anticardiolipin antibodies; anti-β2-GPI: anti-β2-glycoprotein I; LAC: lupus anticoagulants.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 46, Issue 1
1 Jan 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Should aPS/PT Be Incorporated into the Routine Serological Tests in the Diagnosis of Antiphospholipid Syndrome?
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Should aPS/PT Be Incorporated into the Routine Serological Tests in the Diagnosis of Antiphospholipid Syndrome?
SHULAN ZHANG, FENGCHUN ZHANG, YONGZHE LI
The Journal of Rheumatology Jan 2019, 46 (1) 114-116; DOI: 10.3899/jrheum.171402

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Should aPS/PT Be Incorporated into the Routine Serological Tests in the Diagnosis of Antiphospholipid Syndrome?
SHULAN ZHANG, FENGCHUN ZHANG, YONGZHE LI
The Journal of Rheumatology Jan 2019, 46 (1) 114-116; DOI: 10.3899/jrheum.171402
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • To the Editor:
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Promising Imaging Methods for Assessment of Structural Progression in Axial Spondyloarthritis
  • Tumor Necrosis Factor Inhibitor Therapy in Polyarteritis Nodosa: Expanding Evidence From Systemic to Cutaneous Disease
  • Dr. Harama et al reply
Show more Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire